MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 196 filers reported holding MIRATI THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,124 | -100.0% | 400,000 | -30.4% | 1.21% | -56.8% |
| Q3 2022 | $40,158,000 | +99.4% | 575,000 | +91.7% | 2.81% | +84.3% |
| Q2 2022 | $20,139,000 | +389.9% | 300,000 | +500.0% | 1.52% | +382.0% |
| Q1 2022 | $4,111,000 | -62.6% | 50,000 | -33.3% | 0.32% | -51.7% |
| Q4 2021 | $11,002,000 | -48.2% | 75,000 | -37.5% | 0.65% | -24.2% |
| Q3 2021 | $21,229,000 | -24.9% | 120,000 | -31.4% | 0.86% | -10.1% |
| Q2 2021 | $28,268,000 | -40.0% | 175,000 | -36.4% | 0.96% | -8.5% |
| Q1 2021 | $47,108,000 | -34.0% | 275,000 | -15.4% | 1.05% | -38.3% |
| Q4 2020 | $71,383,000 | +56.3% | 325,000 | +18.2% | 1.70% | -3.2% |
| Q3 2020 | $45,664,000 | -20.0% | 275,000 | -45.0% | 1.76% | -19.4% |
| Q2 2020 | $57,085,000 | -45.0% | 500,000 | -63.0% | 2.18% | -54.8% |
| Q1 2020 | $103,775,000 | -54.8% | 1,350,000 | -24.3% | 4.82% | -47.4% |
| Q4 2019 | $229,679,000 | +25.4% | 1,782,392 | -24.2% | 9.16% | -17.8% |
| Q3 2019 | $183,089,000 | +36.7% | 2,350,000 | +80.8% | 11.14% | +44.9% |
| Q2 2019 | $133,900,000 | +69.9% | 1,300,000 | +20.9% | 7.69% | +44.4% |
| Q1 2019 | $78,798,000 | +6.0% | 1,075,000 | -38.6% | 5.33% | -11.7% |
| Q4 2018 | $74,307,000 | -12.8% | 1,751,699 | -3.2% | 6.03% | +8.9% |
| Q3 2018 | $85,251,000 | -9.9% | 1,810,000 | -5.6% | 5.54% | -20.8% |
| Q2 2018 | $94,575,000 | +60.6% | 1,918,350 | 0.0% | 7.00% | +59.4% |
| Q1 2018 | $58,893,000 | +162.0% | 1,918,350 | +55.8% | 4.39% | +86.6% |
| Q4 2017 | $22,475,000 | +92.1% | 1,231,522 | +23.2% | 2.35% | +13.9% |
| Q3 2017 | $11,700,000 | +10.4% | 1,000,000 | +101.9% | 2.07% | +29.4% |
| Q1 2016 | $10,601,000 | -32.3% | 495,356 | 0.0% | 1.60% | -14.7% |
| Q4 2015 | $15,653,000 | +78.3% | 495,356 | +94.3% | 1.87% | +33.6% |
| Q3 2015 | $8,777,000 | – | 255,000 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |